Investors cheer Valeant board change

ReutersNewsPublished: March 9, 201632 views
Published: March 9, 2016

Controversial drug company Valeant Pharmaceuticals, which has been under fire for drug-pricing practices, has added new board members as part of an effort to reassure investors. Bobbi Rebell reports.

Be the first to suggest a tag